SP1 and COVID-19: CD94/NKG2A on NK cells could recognize and interact with HLA-E/peptide (LQPRTFLL) complex derived from SARS-CoV-2 spike 1 protein (SP1), leading to the inhibitory signal for NK cells and the exhaustion of NK cells at the early stages of COVID‐19 [39].